These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15519704)

  • 1. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
    Beeching NJ; Clarke PD; Kitchin NR; Pirmohamed J; Veitch K; Weber F
    Vaccine; 2004 Nov; 23(1):29-35. PubMed ID: 15519704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
    Overbosch D; Peyron F; Picot N; Varichon JP; Dumas R; Chambonneau L; Weber F
    J Travel Med; 2005; 12(6):319-26. PubMed ID: 16343383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interchangeability of Hepatitis A boosters, Avaxim and Vaqta, in healthy adults following a primary dose of the combined typhoid/Hepatitis A vaccine Viatim.
    Ekwall E; Ulgemo A; Watson M; Boisnard F; Thomas S; Goullet F
    Vaccine; 2006 May; 24(20):4450-7. PubMed ID: 16621186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
    Proell S
    BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
    Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults.
    Loebermann M; Kollaritsch H; Ziegler T; Rendi-Wagner P; Chambonneau L; Dumas R; Lafrenz M
    Clin Ther; 2004 Jul; 26(7):1084-91. PubMed ID: 15336473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study.
    Lau CL; Streeton CL; David MC; Sly PD; Mills DJ
    J Travel Med; 2016 Feb; 23(2):tav023. PubMed ID: 26883924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
    Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
    J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity.
    Proell S; Maiwald H; Nothdurft HD; Saenger R; Vollmar J; De Clercq N; von Sonnenburg F
    J Travel Med; 2002; 9(3):122-6. PubMed ID: 12088576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults.
    Beran J; Chlibek R; Weber F
    Vaccine; 2003 Dec; 21(32):4650-4. PubMed ID: 14585671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactogenicity profile of a combined hepatitis A and B vaccine in clinical practice: a naturalistic study in adult travellers.
    Vilella A; Dal-Ré R; Simó D; Puente J; Díez C; García-Corbeira P; Bayas JM
    Vaccine; 2005 Mar; 23(19):2465-9. PubMed ID: 15752832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
    Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
    J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis and typhoid vaccine: killing two birds with one stone.
    Tucker R
    Community Nurse; 1999 Nov; 5(10):41-2. PubMed ID: 10732550
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
    Höhler T; Groeger-Bicanic G; Hoet B; Stoffel M
    Vaccine; 2007 Feb; 25(8):1503-8. PubMed ID: 17097774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis.
    Hewlett AT
    Expert Opin Biol Ther; 2009 Sep; 9(9):1235-40. PubMed ID: 19601727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
    Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
    Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.